Suppr超能文献

神经内分泌肿瘤患者的第二种恶性肿瘤:淋巴瘤——68Ga-DOTANOC 和 18F-FDG 双示踪剂 PET/CT 检查中酷似去分化的表现。

Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.

机构信息

From the Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Clin Nucl Med. 2014 Apr;39(4):358-9. doi: 10.1097/RLU.0b013e31828e98c5.

Abstract

Neuroendocrine tumors (NETs) are rare tumors which express somatostatin receptors (SSTRs). We here present a case of a 50-year-old female patient with metastatic bronchial carcinoid. She underwent 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT which suggested a diagnosis of poorly differentiated NET. Biopsy of the lesion, however, revealed a second malignancy in the form of diffuse large B-cell lymphoma. Thus, very rarely, other primary tumors can mimic NETs on dual-tracer PET/CT, and biopsy is advised in doubtful cases.

摘要

神经内分泌肿瘤(NET)是一种罕见的肿瘤,表达生长抑素受体(SSTR)。我们在此介绍一例 50 岁女性转移性支气管类癌患者。她接受了 68Ga-DOTANOC PET/CT 和 18F-FDG PET/CT 检查,结果提示分化差的 NET 诊断。然而,病变活检显示为弥漫性大 B 细胞淋巴瘤的第二种恶性肿瘤。因此,在双重示踪剂 PET/CT 上,其他原发性肿瘤很少会模拟 NET,在可疑病例中建议进行活检。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验